Histopathology of Eosinophilic Gastrointestinal Diseases Beyond Eosinophilic Esophagitis.
Eosinophilia
Genotype–phenotype correlations
Immune therapy
Journal
Immunology and allergy clinics of North America
ISSN: 1557-8607
Titre abrégé: Immunol Allergy Clin North Am
Pays: United States
ID NLM: 8805635
Informations de publication
Date de publication:
May 2024
May 2024
Historique:
medline:
5
4
2024
pubmed:
5
4
2024
entrez:
4
4
2024
Statut:
ppublish
Résumé
Eosinophilic gastrointestinal diseases (EGID), such as eosinophilic gastritis (EoG), eosinophilic enteritis, and eosinophilic colitis (EoC), are chronic inflammatory conditions characterized by persistent gastrointestinal symptoms and elevated levels of activated eosinophils in the gastrointestinal tract. EoG and eosinophilic duodenitis (EoD) are strongly associated with food allergen triggers and T
Identifiants
pubmed: 38575230
pii: S0889-8561(24)00008-0
doi: 10.1016/j.iac.2024.01.008
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
369-381Informations de copyright
Copyright © 2024 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Disclosures M. Pletneva is a consultant for Allakos. M.H. Collins is a consultant for Allakos, Arena/Pfizer, AstraZeneca, Calypso Biotech, EsoCap Biotech, GlaxoSmithKline, Receptos/Celgene/BMS, Regeneron Pharmaceuticals, Robarts Clinical Trials Inc./Alimentiv, Inc. and Shire, a Takeda company. N.C. Arva, A. Bernieh, O. Lopez-Nunez, and G-Y. Yang do not have conflicts of interest.